Oxidation reduction sensitive green fluorescent protein variants

• US 7,015,310 B2
• Filed: 03/11/2002
• Issued: 03/21/2006
• Est. Priority Date: 03/12/2001
• Status: Expired due to Term

• Current Assignee: Oregon State University (Oregon University System)
• Original Assignee: University of Oregon
• Inventors: Remington, S. James, Hanson, George T.
• Primary Examiner(s): Kerr, Kathleen M.
• Assistant Examiner(s): ROBINSON, HOPE A
• Application Number:
  US10/471,857
• Publication Number:
  US 20040171112A1
• Time in Patent Office: 1,471 Days
• Field of Search: 530/350, 530/300, 435/7.1, 435/69.1, 435/325, 435/252.3, 435/320.1, 514/12, 514/2, 514/21
• US Class Current: 530/350
• CPC Class Codes: C07K 14/43595 from coelenteratae, e.g. medusae

Abstract

The disclosure provides proteins that can be used to determine the redox status of an environment (such as the environment within a cell or subcellular compartment). These proteins are green fluorescent protein (GFP) variants (also referred to as redox sensitive GFP (rosGFP) mutants), which have been engineered to have two cysteine amino acids near the chromophore and within disulfide bonding distance of each other. Also provided are nucleic acid molecules that encode rosGFPs, vectors containing such encoding molecules, and cells transformed therewith. The disclosure further provides methods of using the rosGFPs (and encoding molecules) to analyze the redox status of an environment, such as a cell, or a subcellular compartment within a cell. In certain embodiments, both redox status and pH are analyzed concurrently.

Claims

1. An isolated mutant green fluorescent protein (GFP), with a fluorescence spectrum that is sensitive to redox status,

wherein said mutant GFP shares at least 90% sequence identity with SEQ ID NO:

1 and

wherein mutations at positions corresponding to SEQ ID NO;

1 include;

a) having a cysteine at one or both of the residues corresponding to 147 or 149 of SEQ ID NO;

1 and

b) having a cysteine at one or both of the residues corresponding to 202 or 204 of SEQ ID NO;

1.

2. The mutant GFP of claim 1, wherein the mutations are selected from the group consisting of:

a) the residues corresponding to 147 and 202 of SEQ ID NO;

1 are cysteine;

b) the residues corresponding to 147 and 204 of SEQ ID NO;

1 are cysteine;

c) the residues corresponding to 149 and 202 of SEQ ID NO;

1 are cysteine;

d) the residues corresponding to 149 and 204 of SEQ ID NO;

1 are cysteine; and

e) the residues corresponding to each of residues 147, 149, 202, and 204 of SEQ ID NO;

1 are cysteine.

3. The mutant GFP of claim 1, comprising an additional mutation with respect to SEQ ID NO:

1 corresponding to position 65.

4. The mutant GFP of claim 3, wherein the residue corresponding to position 65 in SEQ ID NO:

1 is threonine.

5. The mutant GFP of claim 1, wherein the fluorescence spectrum is also pH sensitive.

6. The mutant GFP of claim 1, comprising an additional mutation with respect to SEQ ID NO:

1 corresponding to position 48.

7. The mutant GFP of claim 6, wherein the residue corresponding to position 48 in SEQ ID NO:

1 is serine.

8. The mutant GFP of claim 1, comprising additional mutations with respect to SEQ ID NO:

1 corresponding to positions 48, 65, 149, and 202,

wherein the residues corresponding to positions 48, 65, 149, and 202 are serine, threonine, cysteine, and cysteine, respectively.

9. The mutant GFP of claim 1, comprising additional mutations with respect to SEQ ID NO:

1 corresponding to positions 48, 65, 149, and 204,

wherein the residues corresponding to positions 48, 65, 149, and 204 are serine, threonine, cysteine, and cysteine, respectively.

10. The mutant GFP of claim 1, comprising additional mutations with respect to SEQ ID NO:

1 corresponding to positions 48, 147, and 204,

wherein the residues corresponding to positions 48, 147, and 204 are serine, cysteine, and cysteine, respectively.

11. The mutant GFP of claim 1, comprising additional mutations with respect to SEQ ID NO:

1 corresponding to positions 48, 147, and 202,

wherein the residues corresponding to positions 48, 147, and 202 are serine, cysteine, and cysteine, respectively.

12. The mutant GFP of claim 1, comprising additional mutations with respect to SEQ ID NO:

1 corresponding to positions 48, 65, 147, 149, 202, and 204,

wherein the residues corresponding to positions 48, 65, 147, 149, 202, and 204 are serine, threonine, cysteine, cysteine, cysteine, and cysteine, respectively.

13. The mutant GFP of claim 1, comprising additional mutations with respect to SEQ ID NO:

1 corresponding to positions 48, 147, 149, 202, and 204,

wherein the residues corresponding to positions 48, 147, 149, 202, and 204 are serine, cysteine, cysteine, cysteine, and cysteine, respectively.

14. A method of analyzing an oxidation-reduction condition of or in a cell comprising:

expressing the mutant GFP of claim 1 in the cell; and

measuring fluorescence signal from the mutant GFP, thereby analyzing an oxidation-reduction condition of or in a cell.

15. The method of claim 14, wherein the mutant GFP is expressed as a fusion protein.

16. The method of claim 14, further comprising analyzing a pH condition of or in the cell using the mutant GFP.

17. The mutant GFP of claim 1, comprising an amino acid sequence as shown in SEQ ID NO:

3, SEQ ID NO;

5, SEQ ID NO;

7, SEQ ID NO;

9, SEQ ID NO;

11, or SEQ ID NO;

13.

18. A mutant GFP, with a fluorescence spectrum that is sensitive to redox status,

wherein said mutant GFP shares at least 90% sequence identity with SEQ ID NO:

1 and includes mutations selected from the group consisting of;

a) the residues corresponding to 147 and 204 of SEQ ID NO;

1 are cysteine and cysteine, respectively;

b) the residues corresponding to 65, 147 and 204 of SEQ ID NO;

1 are threonine, cysteine, and cysteine respectively;

c) the residues corresponding to 149 and 202 of SEQ ID NO;

1 are cysteine and cysteine, respectively;

d) the residues corresponding to 65, 149 and 202 of SEQ ID NO;

1 are threonine, cysteine, and cysteine respectively;

e) the residues corresponding to 147, 149, 202 and 204 of SEQ ID NO;

1 are cysteine, cysteine, cysteine and cysteine, respectively; and

f) the residues corresponding to 65, 147, 149, 202 and 204 of SEQ ID NO;

1 are threonine, cysteine, cysteine, cysteine and cysteine, respectively.

19. A mutant GFP, with a fluorescence spectrum that is sensitive to redox status,

wherein said mutant GFP shares at least 95% sequence identity with SEQ ID NO:

1 and includes mutations selected from the group consisting of;

a) the residues corresponding to 147 and 204 of SEQ ID NO;

1 are cysteine and cysteine, respectively;

b) the residues corresponding to 65, 147 and 204 of SEQ ID NO;

1 are threonine, cysteine, and cysteine respectively;

c) the residues corresponding to 149 and 202 of SEQ ID NO;

1 are cysteine and cysteine, respectively;

d) the residues corresponding to 65, 149 and 202 of SEQ ID NO;

1 are threonine, cysteine, and cysteine respectively;

e) the residues corresponding to 147, 149, 202 and 204 of SEQ ID NO;

1 are cysteine, cysteine, cysteine and cysteine, respectively; and

f) the residues corresponding to 65, 147, 149, 202 and 204 of SEQ ID NO;

1 are threonine, cysteine, cysteine, cysteine and cysteine, respectively.

20. An isolated mutant GFP, with a fluorescence spectrum that is sensitive to redox status,

wherein said mutant GFP shares at least 95% sequence identity with SEQ ID NO:

1 and

wherein mutations at positions corresponding to SEQ ID NO;

1 include;

a) having a cysteine at one or both of the residues corresponding to 147 or 149 of SEQ ID NO;

1 and

b) having a cysteine at one or both of the residues corresponding to 202 or 204 of SEQ ID NO;

1.

21. The mutant GFP of claim 20, wherein the mutations are selected from the group consisting of:

a) the residues corresponding to 147 and 202 of SEQ ID NO;

1 are cysteine;

b) the residues corresponding to 147 and 204 of SEQ ID NO;

1 are cysteine;

c) the residues corresponding to 149 and 202 of SEQ ID NO;

1 are cysteine;

d) the residues corresponding to 149 and 204 of SEQ ID NO;

1 are cysteine; and

e) the residues corresponding to each of residues 147, 149, 202, and 204 of SEQ ID NO;

1 are cysteine.

22. The mutant GFP of claim 20, comprising an additional mutation with respect to SEQ ID NO:

1 corresponding to position 65.

23. The mutant GFP of claim 22, wherein the residue corresponding to position 65 in SEQ ID NO:

1 is threonine.

24. The mutant GFP of claim 20, wherein the fluorescence spectrum is also pH sensitive.

25. The mutant GFP of claim 20, comprising an additional mutation with respect to SEQ ID NO:

1 corresponding to position 48.

26. The mutant GFP of claim 25, wherein the residue corresponding to position 48 in SEQ ID NO:

1 is serine.